Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (12): 1287-1291.DOI: 10.3969/j.issn.1673-8640.2021.12.019
Previous Articles Next Articles
ZHU Yonglin1, WANG Lüya2, YAN Shengkai1()
Received:
2021-07-29
Online:
2021-12-30
Published:
2021-12-29
Contact:
YAN Shengkai
CLC Number:
ZHU Yonglin, WANG Lüya, YAN Shengkai. Research progress in the methodology and clinical application of low-density lipoprotein receptor gene mutation and function determination[J]. Laboratory Medicine, 2021, 36(12): 1287-1291.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.12.019
检测方法 | 原理 | 优点 | 缺点 | 应用示例 |
---|---|---|---|---|
Sanger测序 | 利用双脱氧核苷酸可终止聚合酶联反应的原理 | 可检测长序列和5%的小等位基因片段;基因测序金标准;样本少时效益高 | 样本多时效益低;成本高;速度慢 | 225例受试者中发现了LDLR基因的7个致病突变和5个良性突变[ |
NGS | 通过捕捉新添加碱基携带的特殊标记来确定DNA序列 | 高通量;可同时测序多个基因;可发现新变异;测序深度、灵敏度高 | 样本少时效益低;需进行生物信息学分析 | 148例阳性突变患者中发现了77例LDLR基因杂合型突变和5例LDLR基因纯合型突变[ |
MLPA | 在靶序列变异位点两侧设计1对探针,经杂交、连接、聚合酶联反应扩增、产物分离及数据分析后得出结果 | CNV的金标准;简单、成本低;突变检测阴性后使用 | 仅针对LDLR基因;不能检测单细胞和未知位点;对探针附近新的良性多态性敏感 | 在新加坡人群中检出4例大的LDLR基因新重排突变[ |
检测方法 | 原理 | 优点 | 缺点 | 应用示例 |
---|---|---|---|---|
Sanger测序 | 利用双脱氧核苷酸可终止聚合酶联反应的原理 | 可检测长序列和5%的小等位基因片段;基因测序金标准;样本少时效益高 | 样本多时效益低;成本高;速度慢 | 225例受试者中发现了LDLR基因的7个致病突变和5个良性突变[ |
NGS | 通过捕捉新添加碱基携带的特殊标记来确定DNA序列 | 高通量;可同时测序多个基因;可发现新变异;测序深度、灵敏度高 | 样本少时效益低;需进行生物信息学分析 | 148例阳性突变患者中发现了77例LDLR基因杂合型突变和5例LDLR基因纯合型突变[ |
MLPA | 在靶序列变异位点两侧设计1对探针,经杂交、连接、聚合酶联反应扩增、产物分离及数据分析后得出结果 | CNV的金标准;简单、成本低;突变检测阴性后使用 | 仅针对LDLR基因;不能检测单细胞和未知位点;对探针附近新的良性多态性敏感 | 在新加坡人群中检出4例大的LDLR基因新重排突变[ |
类别 | 检测目的 | 检测方法 | 检测原理 | 应用情况 |
---|---|---|---|---|
荧光分 析法 | LDLR的表达 | 抗体标记法 | FACS检测LDLR抗体的荧光强度 | 常用 |
间接免疫荧光法 | FACS检测荧光二抗的荧光强度 | 常用 | ||
免疫印迹法 | 凝胶图像处理系统分析条带强度 | 常用 | ||
LDLR结合LDL的能力 | FACS检测法 | FACS定量检测LDLR结合LDL的量 | 常用 | |
CLSM检测法 | CLSM可视化观察LDLR结合LDL | 常用 | ||
放射性 分析法 | LDLR的表达 | 放射性物质标记法 | 化学发光法检测细胞内125I-IgG-C7的放射性 | 常用(但正在被荧光分析法取代) |
LDLR结合LDL的能力 | 放射性物质标记法 | 化学发光法检测肝素的放射性 |
类别 | 检测目的 | 检测方法 | 检测原理 | 应用情况 |
---|---|---|---|---|
荧光分 析法 | LDLR的表达 | 抗体标记法 | FACS检测LDLR抗体的荧光强度 | 常用 |
间接免疫荧光法 | FACS检测荧光二抗的荧光强度 | 常用 | ||
免疫印迹法 | 凝胶图像处理系统分析条带强度 | 常用 | ||
LDLR结合LDL的能力 | FACS检测法 | FACS定量检测LDLR结合LDL的量 | 常用 | |
CLSM检测法 | CLSM可视化观察LDLR结合LDL | 常用 | ||
放射性 分析法 | LDLR的表达 | 放射性物质标记法 | 化学发光法检测细胞内125I-IgG-C7的放射性 | 常用(但正在被荧光分析法取代) |
LDLR结合LDL的能力 | 放射性物质标记法 | 化学发光法检测肝素的放射性 |
[1] |
ALABI A, XIA X D, GU H M, et al. Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis[J]. Nat Commun, 2021, 12(1):1889.
DOI URL |
[2] |
BENITO-VICENTE A, URIBE K B, JEBARI S, et al. Validation of LDLr activity as a tool to improve genetic diagnosis of familial hypercholesterolemia:a retrospective on functional characterization of LDLr variants[J]. Int J Mol Sci, 2018, 19(6):1676.
DOI URL |
[3] |
ABDUL N S, CHUTURGOON A A. Fumonisin B1 regulates LDL receptor and ABCA1 expression in an LXR dependent mechanism in liver(HepG2) cells[J]. Toxicon, 2021, 190:58-64.
DOI URL |
[4] |
LIU C, KIM Y S, KIM J, et al. Modeling hypercholesterolemia and vascular lipid accumulation in LDL receptor mutant zebrafish[J]. J Lipid Res, 2018, 59(2):391-399.
DOI URL |
[5] |
ABIFADEL M, VARRET M, RABÈS J P, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia[J]. Nat Genet, 2003, 34(2):154-156.
DOI URL |
[6] |
ADAM R C, MINTAH I J, ALEXA-BRAUN C A, et al. Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance[J]. J Lipid Res, 2020, 61(9):1271-1286.
DOI URL |
[7] |
BANERJEE P, CHAN K C, TARABOCCHIA M, et al. Functional analysis of LDLR(low-density lipoprotein receptor) variants in patient lymphocytes to assess the effect of evinacumab in homozygous familial hypercholesterolemia patients with a spectrum of LDLR activity[J]. Arterioscler Thromb Vasc Biol, 2019, 39(11):2248-2260.
DOI URL |
[8] | 张明明, 宋光耀. 高胆固醇血症低密度脂蛋白受体基因突变的研究进展[J]. 河北医科大学学报, 2011, 32(7):866-868. |
[9] | MOLDOVAN V, BANESCU C, DOBREANU M. Molecular diagnosis methods in familial hypercholesterolemia[J]. Anatol J Cardiol, 2020, 23(3):120-127. |
[10] |
LEE C, CUI Y, SONG J, et al. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction[J]. Lipids Health Dis, 2019, 18(1):95.
DOI URL |
[11] | LAMIQUIZ-MONEO I, CIVEIRA F, MATEO-GALLEGO R, et al. Diagnostic yield of sequencing familial hypercholesterolemia genes in individuals with primary hypercholesterolemia[J]. Rev Esp Cardiol(Engl Ed), 2021, 74(8):664-673. |
[12] |
SUN D, ZHOU B Y, LI S, et al. Genetic basis of index patients with familial hypercholesterolemia in Chinese population:mutation spectrum and genotype-phenotype correlation[J]. Lipids Health Dis, 2018, 17(1):252.
DOI URL |
[13] |
PEK S L T, DISSANAYAKE S, FONG J C W, et al. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore:single center study[J]. Atherosclerosis, 2018, 269:106-116.
DOI URL |
[14] | 中华医学会心血管病学分会动脉粥样硬化及冠心病学组, 中华心血管病杂志编辑委员会. 家族性高胆固醇血症筛查与诊治中国专家共识[J]. 中华心血管病杂志, 2018, 46(2):99-103. |
[15] |
ALVES A C, AZEVEDO S, BENITO-VICENTE A, et al. LDLR variants functional characterization:contribution to variant classification[J]. Atherosclerosis, 2021, 329:14-21.
DOI URL |
[16] |
LEE S, AKIOYAMEN L E, ALJENEDIL S, et al. Genetic testing for familial hypercholesterolemia:impact on diagnosis,treatment and cardiovascular risk[J]. Eur J Prev Cardiol, 2019, 26(12):1262-1270.
DOI URL |
[17] |
HSIUNG Y C, LIN P C, CHEN C S, et al. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan[J]. Atherosclerosis, 2018, 277:440-447.
DOI URL |
[18] | 代海兵, 王绿娅, 鄢盛恺. 植物固醇血症及其实验室诊断研究进展[J]. 中华检验医学杂志, 2021, 44(11):1079-1082. |
[19] | LEE W J, CHUANG H N, CHEN Y M, et al. Familial hypercholesterolemia genetic variations and long-term cardiovascular outcomes in patients with hypercholesterolemia who underwent coronary angiography[J]. Genes(Basel), 2021, 12(9):1413. |
[20] |
TRINDER M, FRANCIS G A, BRUNHAM L R. Association of monogenic vs polygenic hypercholesterolemia with risk of atherosclerotic cardiovascular disease[J]. JAMA Cardiol, 2020, 5(4):390-399.
DOI URL |
[21] |
STURM A C, KNOWLES J W, GIDDING S S, et al. Clinical genetic testing for familial hypercholesterolemia:JACC scientific expert panel[J]. J Am Coll Cardiol, 2018, 72(6):662-680.
DOI URL |
[22] | MARTIN A C, HOOPER A J, NORMAN R, et al. Pilot study of universal screening of children and child-parent cascade testing for familial hypercholesterolaemia in Australia[J]. J Paediatr Child Health, 2021. |
[23] |
ROMANO M, DI TARANTO M D, MIRABELLI P, et al. An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations[J]. J Lipid Res, 2011, 52(11):2095-2100.
DOI URL |
[24] |
MELZER S, NUNES C S, ENDRINGER D C, et al. Trypan blue as an affordable marker for automated live-dead cell analysis in image cytometry[J]. Scanning, 2016, 38(6):857-863.
DOI URL |
[25] |
BEISIEGEL U, SCHNEIDER W J, GOLDSTEIN J L, et al. Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia[J]. J Biol Chem, 1981, 256(22):11923-11931.
DOI URL |
[26] |
IACOCCA M A, CHORA J R, CARRIÉ A, et al. ClinVar database of global familial hypercholesterolemia-associated DNA variants[J]. Hum Mutat, 2018, 39(11):1631-1640.
DOI URL |
[27] |
CHORA J R, MEDEIROS A M, ALVES A C, et al. Analysis of publicly available LDLR,APOB,and PCSK9 variants associated with familial hypercholesterolemia:application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis[J]. Genet Med, 2018, 20(6):591-598.
DOI URL |
[28] | BJORNSSON E, GUNNARSDOTTIR K, HALLDORSSON G H, et al. Lifelong reduction in LDL(low-density lipoprotein) cholesterol due to a gain-of-function mutation in LDLR[J]. Circ Genom Precis Med, 2021, 14(1):e003029. |
[29] | JIANG L, SUN L Y, PAN X D, et al. Characterization of the unique Chinese W483X mutation in the low-density lipoprotein-receptor gene in young patients with homozygous familial hypercholesterolemia[J]. J Clin Lipidol, 2016,10(3):538-546.e5. |
[30] |
CHENG S, WU Y, WEN W, et al. Independent severe cases of heterozygous familial hypercholesterolemia caused by the W483X and novel W483G mutations in the low-density lipoprotein receptor gene that were clinically diagnosed as homozygous cases[J]. Genet Test Mol Biomarkers, 2019, 23(6):401-408.
DOI URL |
[1] | FU Yi, YANG Xuesong, JIN Ligang, ZHAI Hongli, JIN Xiaoling. Correlation between small and dense low-density lipoprotein cholesterol and acute coronary syndrome with the occurrence of long-term adverse cardiovascular events [J]. Laboratory Medicine, 2023, 38(9): 878-883. |
[2] | MA Jianguo, LI Hongchun. Correlation between blood lipid levels and cardiac function indexes in patients with coronary heart disease [J]. Laboratory Medicine, 2023, 38(7): 659-664. |
[3] | SU Zhenzhen, ZOU Jihua, WANG Huimin, XU Weifeng, DING Fang, ZHANG Jingmei, WANG Zhanke. Consistency of serum LDL-P and LDL-C determination results [J]. Laboratory Medicine, 2023, 38(2): 148-152. |
[4] | XING Baobao, CAO Yinfang. Predictive value of sd-LDL-C/LDL-C ratio for in-stent restenosis in patients with AMI after interventional therapy [J]. Laboratory Medicine, 2023, 38(10): 941-945. |
[5] | ZHANG Yifan, LI Changping, ZHANG Lili, CHEN Zhong. Relationship between plasma galectin 3 and low-density lipoprotein cholesterol stratified by ages in patients with cardiovascular disease [J]. Laboratory Medicine, 2023, 38(1): 8-13. |
[6] | CHEN Yuemei, JIN Yongmei, ZENG Tingting, JIANG Nenggang, LIAO Hongyan. Diagnosis and clinical characteristics of acute myeloid leukemia with BCR-ABL1 accompanied by FLT3-ITD and multiple gene mutations [J]. Laboratory Medicine, 2022, 37(4): 365-369. |
[7] | SHEN Ying, XU Xiaoping, ZHANG Lele, DU Yongping, MENG Chao. Clinical value of LDL-C determination in non-fasting blood samples [J]. Laboratory Medicine, 2022, 37(11): 1049-1056. |
[8] | PENG Yanjun, HAN Xuejing, TANG Hongxia, CHEN Junmeng, JIA Kegang. Correlation between nuclear magnetic resonance spectroscopy and traditional biochemical determination methods analyzer for determining blood lipid [J]. Laboratory Medicine, 2021, 36(7): 733-737. |
[9] | LI Jing, QUAN Hui, ZENG Zhirong, WEI Yi. Establishment of the reference interval of small and dense low-density lipoprotein cholesterol in apparently healthy adults in Chengdu [J]. Laboratory Medicine, 2021, 36(6): 609-614. |
[10] | YUAN Muge, WU Wenjian, HU Zhaohui, CHEN Jiachang, YU Shihui, OU Xiaohua, MAO Linlin, WU Haiyan. Germline mutation detection in early-stage breast cancer by next-generation sequencing [J]. Laboratory Medicine, 2021, 36(3): 325-329. |
[11] | ZHENG Hongxue, CHEN Yao, YIN Liping, LI Xin, DING Yu, LI Juan, WANG Xiumin. Analysis of clinical features and genetic variation of Sotos syndrome [J]. Laboratory Medicine, 2021, 36(2): 130-134. |
[12] | ZHAO Jingjing, ZHANG Peng, ZHOU Yong, CAO Yingping, HUANG Zhihu, FU Shengmiao, WANG Yuming, HONG Guolin, SHEN Jun, ZHENG Lei. A preliminary study on Lp-PLA2 and its relationship with LDL-C and hs-CRP in southern China [J]. Laboratory Medicine, 2021, 36(12): 1222-1228. |
[13] | SHI Yue, DONG Dong. Research progress of circulating tumor DNA in renal cell carcinoma [J]. Laboratory Medicine, 2020, 35(9): 952-956. |
[14] | DU Jinlong, FENG Yan, LI Hengtao. Role of real-time fluorescence quantitative PCR-binding probe in the determination of MP and MP drug resistance [J]. Laboratory Medicine, 2020, 35(6): 535-539. |
[15] | SUN Ye, GUO Ping, XIONG Shumin, WU Rong, KANG Xiangdong. Retrospective analysis of clinical and laboratory examinations' characteristics of mast cell leukemia [J]. Laboratory Medicine, 2019, 34(2): 180-184. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||